At a glance
ClinicalIndex Comparison RecordN/ACompleted· 51 enrolled
Drug / intervention
Probiotic +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized, Double Blind, Placebo-controlled Intervention Study to Evaluate Safety and Efficiency of a Probiotic in Symptoms Reduction and Use of Topic Corticoids in Mild Atopic Dermatitis Patients Aged 4 to 17 Years
In Brief
A clinical study evaluating Probiotic and Placebo for Dermatitis, Atopic. Completed, enrolled 51 participants across 1 site.
Detailed Summary
The aim of the study is to evaluate the beneficial effect of a probiotic preparation with an antiinflammatory and modulating activity on immunological processes, with positive results on different inflammatory and atopic conditions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDermatitis, Atopic
CountriesSpain
CollaboratorsKorott, S.L.
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedOct 2015
Enrollment StartJan 2016
Primary CompletionJul 2016
Study CompletionAug 2016
TodayJul 2026
First PostedOct 26, 2015
Enrollment StartJan 1, 2016
Primary CompletionJul 1, 2016
Study CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 10.7 years ago
Interventions
Probioticdietary
daily intake of 1 capsule probiotic
Placebodietary
daily intake of 1 capsule containing placebo